EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic analysis and antimicrobial resistance of Vibrio cholerae isolated during Zambia’s 2023 cholera epidemic

Harriet Ng'ombe, Charlie C Luchen, Lia Bote, Mpanga Kasonde, Kunda Musonda, Kapambwe K Mwape, Dhvani H Kuntawala, Suwilanji Silwamba, Mwelwa Chibuye, Kennedy Chibesa, Nyuma Mbewe, Samuel Bosomprah und 10 weitere

Microbial Genomics · 2025

DOI: 10.1099/mgen.0.001566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2025. Verfasst von Harriet Ng'ombe und 21 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia. Hauptthemen laut MEDLINE: Cholera, Vibrio cholerae, Drug Resistance, Bacterial. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cholera, caused by Vibrio cholerae , remains a priority public health concern, particularly in developing countries. The first cholera outbreak in Zambia was documented in the 1970s, with recurring epidemics reported since then. In 2023, a cholera outbreak affected Zambia, particularly in districts bordering Malawi, Mozambique and the Democratic Republic of Congo, with significant cases reported in these neighbouring countries. This study aims to analyse cholera cases and isolates obtained during the 2023 epidemic, focusing on geographical distribution, genetic relatedness of isolates and their antibiotic resistance profiles.

Methods

Stool samples were collected from patients presenting with cholera-like symptoms across three provinces of Zambia. A total of 98 samples were cultured on thiosulphate citrate bile salts sucrose agar, resulting in 32 sequenced V. cholerae isolates. Whole-genome sequencing was performed using Oxford Nanopore Technology, and phylogenetic inference was also achieved by the analysis of SNPs. Phenotypic antimicrobial resistance testing was conducted following Clinical and Laboratory Standards Institute guidelines. The genomic data were analysed for virulence factors and antimicrobial resistance profiles.

Results

Of the 98 stool samples tested, 38 confirmed cholera cases were identified. A subset of 32 confirmed V. cholerae isolates, predominantly from the Eastern Province of Zambia ( n =21), was selected for whole-genome sequencing. Genomic analysis revealed that all isolates belonged to the seventh pandemic El Tor lineage and the O1 serogroup, with two distinct clades identified corresponding to the 10th (T10) and 15th (T15) transmission events. Geographical analysis indicated a predominance of Ogawa serotypes in Eastern Province and Inaba in Northern Province. The virulence gene analysis confirmed the presence of key cholera toxin genes ( ctxA and ctxB ) and intestinal colonization factors. All isolates carried genes or mutations predicted to confer resistance to multiple antibiotics, including decreased susceptibility to ciprofloxacin, recommended for the treatment of cholera by the World Health Organization.

Conclusion

The findings highlight the critical need for enhanced surveillance and targeted interventions to mitigate cholera outbreaks in Zambia. The emergence of resistant V. cholerae strains necessitates innovative strategies, including improved water sanitation, vaccination efforts and novel therapeutic approaches to combat this enduring public health threat.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholeraVibrio choleraeDrug Resistance, BacterialZambiaHumansPhylogenyWhole Genome SequencingAnti-Bacterial AgentsFecesMicrobial Sensitivity TestsVirulence FactorsEpidemicsMaleAdultFemaleGenome, BacterialGenomicsAdolescentYoung Adult

Stichwörter der Autor:innen

Oxford Nanopore TechnologiesVibrio choleraeZambiaantimicrobial resistanceepidemic

Substanzen

Anti-Bacterial AgentsVirulence Factors

Autor:innen und Institutionen

  • Research Division, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
  • Centre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa.
  • Amsterdam UMC, Department of Global Health, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.
  • Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.
  • Zambia National Public Health Institute, Stand 1186, Corner of Chaholi & Addis Ababa Roads, Rhodes Park, Lusaka, Zambia.
  • Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.

Förderung

  • Wellcome Trust

Zitieren

APA

Ng'ombe, H., Luchen, C. C., Bote, L., Kasonde, M., Musonda, K., Mwape, K. K., Kuntawala, D. H., Silwamba, S., Chibuye, M., Chibesa, K., Mbewe, N., Bosomprah, S., Khan, W., Liebenberg, L., de Oliveira, T., Wilkinson, E., Dorman, M. J., Coghlan, A., Simuyandi, M., …, & Thomson, N. R. (2025). Genomic analysis and antimicrobial resistance of Vibrio cholerae isolated during Zambia’s 2023 cholera epidemic. Microbial Genomics. https://doi.org/10.1099/mgen.0.001566

Vancouver

Ng'ombe H, Luchen CC, Bote L, Kasonde M, Musonda K, Mwape KK, et al. Genomic analysis and antimicrobial resistance of Vibrio cholerae isolated during Zambia’s 2023 cholera epidemic. Microbial Genomics. 2025. doi:10.1099/mgen.0.001566

BibTeX
@article{Ngombe2025,
  author = {Ng'ombe, Harriet and Luchen, Charlie C and Bote, Lia and Kasonde, Mpanga and Musonda, Kunda and Mwape, Kapambwe K and Kuntawala, Dhvani H and Silwamba, Suwilanji and Chibuye, Mwelwa and Chibesa, Kennedy and Mbewe, Nyuma and Bosomprah, Samuel and Khan, Wesaal and Liebenberg, Lenine and de Oliveira, Tulio and Wilkinson, Eduan and Dorman, Matthew J and Coghlan, Avril and Simuyandi, Michelo and Chilengi, Roma and Chisenga, Caroline and Thomson, Nicholas R},
  title = {Genomic analysis and antimicrobial resistance of Vibrio cholerae isolated during Zambia’s 2023 cholera epidemic},
  journal = {Microbial Genomics},
  year = {2025},
  doi = {10.1099/mgen.0.001566}
}
Kostenlos starten →